Vergleich retardierter, oraler opioid-analgetika unterdifferenzialtherapeutischen aspekten bei tumorschmerzpatienten

Research output: Contribution to journalResearch articleContributedpeer-review


  • R. Sabatowski - , University Comprehensive Pain Centre, University Hospital Carl Gustav Carus Dresden (Author)
  • R. Scharnagel - , University Hospital Carl Gustav Carus Dresden (Author)


The majority of all cancer patients are suffering from severe pain. A lot of aspects must be taken into consideration when applying the effective opioids available for long-term treatment of chronic pain. These are comorbidity, appearance of active and non-active metabolites, side effects, co-medication and their relevance with regard to interaction, compliance, immunosuppressive effects as well as the individual preferences of the patients.

Translated title of the contribution
Comparison of oral sustained-release strong opioids considering differential therapeutic aspects in patients with tumor-related pain


Original languageGerman
Pages (from-to)S12-S15
JournalTumor Diagnostik und Therapie
Issue numberSUPPL. 1
Publication statusPublished - 2009


Sustainable Development Goals

ASJC Scopus subject areas


  • Hydromorphone, Immunosupression, Morphine, Opioid rotation, Opioids, Oxycodone